American Thoracic Society/ European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2003, 168: 818-900.
Article
Google Scholar
Lomas DA: Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency. COPD. 2013, 10 (Suppl 1): 17-25.
Article
PubMed
Google Scholar
Stoller JK, Aboussouan LS: A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012, 185: 246-259. 10.1164/rccm.201108-1428CI.
Article
CAS
PubMed
Google Scholar
Rudnick DA, Perlmutter DH: Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology. 2005, 42: 514-521. 10.1002/hep.20815.
Article
CAS
PubMed
Google Scholar
Zhou H, Fischer HP: Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol. 1998, 22: 742-748. 10.1097/00000478-199806000-00012.
Article
CAS
PubMed
Google Scholar
Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, Thibodeau SN, Katzmann JA, Allen MS, Midthun DE, Marks RS, de Andrade M: Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008, 168: 1097-1103. 10.1001/archinte.168.10.1097.
Article
PubMed
PubMed Central
Google Scholar
Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, Lindor NM, Myers JL, Wiegert E, Midthun DE, Thibodeau SN, Krowka MJ: Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1999, 8: 461-465.
CAS
PubMed
Google Scholar
Sun Z, Yang P: Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 2004, 5: 182-190. 10.1016/S1470-2045(04)01414-7.
Article
CAS
PubMed
Google Scholar
Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, Taylor WR, Marks RS, Deschamps C, Swensen SJ, Wieben ED, Cunningham JM, Melton LJ, de Andrade M: Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest. 2005, 128: 445-452. 10.1378/chest.128.1.445.
Article
CAS
PubMed
Google Scholar
Benkmann HG, Hanssen HP, Ovenbeck R, Goedde HW: Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients. Hum Hered. 1987, 37: 290-293. 10.1159/000153720.
Article
CAS
PubMed
Google Scholar
Callea F, Stuyck JM, Massi G, Huyghe JD, Van Gijsegem DF, Jadoul DH, Desmet VJ: Alpha-1-antitrypsin (AAT) deposits in gall bladder adenocarcinoma and liver in partial AAT deficiency (Pi SZ phenotype). Am J Clin Pathol. 1982, 78: 878-883.
Article
CAS
PubMed
Google Scholar
Callea F, Massi G, De Wolf-Peeters C, Lievens C, Desmet VJ: Alpha-1-antitrypsin phenotypes in malignant lymphoma. J Clin Pathol. 1982, 35: 1213-1215. 10.1136/jcp.35.11.1213.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang P, Cunningham JM, Halling KC, Lesnick TG, Burgart LJ, Wiegert EM, Christensen ER, Lindor NM, Katzmann JA, Thibodeau SN: Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab. 2000, 71: 639-645. 10.1006/mgme.2000.3089.
Article
CAS
PubMed
Google Scholar
Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B, Hopper J, Jass J, Jenkins M, Templeton A, Potter J, Newcomb PA, Lemarchand L, Grove J, Haile R, Baron J, Seminara D, Limburg P, Thibodeau SN: Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab. 2010, 99: 157-159. 10.1016/j.ymgme.2009.09.010.
Article
CAS
PubMed
Google Scholar
Blanco I, Fernández E, Rodríguez MC, Fernández A: Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias. Med Clin (Barc). 1999, 113: 366-370.
CAS
Google Scholar
Blanco I, Fernández E: Alpha1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys. Respir Med. 2001, 95: 109-114. 10.1053/rmed.2000.0964.
Article
CAS
PubMed
Google Scholar
Pérez-Holanda S, Rodrigo L, Pinyol-Felis C, Vinyas-Salas J: Colonic perianastomotic carcinogenesis in an experimental model. BMC Cancer. 2008, 8: 217-10.1186/1471-2407-8-217.
Article
PubMed
PubMed Central
Google Scholar
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ: National comprehensive cancer network. Colon cancer clinical practice guidelines in oncology. Natl Compr Canc Netw. 2005, 3: 468-491.
Google Scholar
de Serres FJ, Blanco I, Fernández-Bustillo E: Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain. Clin Genet. 2003, 63: 490-509. 10.1034/j.1399-0004.2003.00078.x.
Article
CAS
PubMed
Google Scholar
Blanco I, de Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M: Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J. 2006, 27: 77-84. 10.1183/09031936.06.00062305.
Article
CAS
PubMed
Google Scholar
Ward AM, Cooper EH, Turner R, Anderson JA, Neville AM: Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer. 1977, 35: 170-178. 10.1038/bjc.1977.24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bernacka K, Kurryliszyn-Moskal A, Sierakowski S: The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancer during diagnosis. Cancer. 1988, 62: 1188-1193. 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Stamatiadis AP, Toumanidou MS, Vyssoulis GP, Mnouras AJ, Apostolidis NS: Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. Cancer. 1990, 65: 2055-2057. 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6.
Article
CAS
PubMed
Google Scholar
Bujanda L, Sarasqueta C, Cosme A, Hijona E, Enríquez-Navascués JM, Placer C, Villarreal E, Herreros-Villanueva M, Giraldez MD, Gironella M, Balaguer F, Castells A: Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer. PLoS One. 2013, 8: e51810-10.1371/journal.pone.0051810.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harris CC, Cohen MH, Connor R, Primack A, Saccomanno G, Talamo RC: Serum alpha1-antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer. 1976, 38: 1655-1657. 10.1002/1097-0142(197610)38:4<1655::AID-CNCR2820380435>3.0.CO;2-F.
Article
CAS
PubMed
Google Scholar
Daddi G, Mancini PA, Parola D, Matzeu M: Behaviour of alpha1-antitrypsin in lung cancer. Scand J Respir Dis Suppl. 1978, 102: 205-206.
CAS
PubMed
Google Scholar
Hansen JE, Iversen J, Lihme A, Bøg-Hansen TC: Acute phase reaction, heterogeneity, and microheterogeneity of serum proteins as nonspecific tumor markers in lung cancer. Cancer. 1987, 60: 1630-1635. 10.1002/1097-0142(19871001)60:7<1630::AID-CNCR2820600735>3.0.CO;2-X.
Article
CAS
PubMed
Google Scholar
Ferrigno D, Buccheri G, Camilla T: Prognosis and lung-cancer - the contribution of plasma-proteins. Oncol Rep. 1995, 2: 637-641.
CAS
PubMed
Google Scholar
Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P: Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol. 2011, 6: 291-295. 10.1097/JTO.0b013e31820213fb.
Article
PubMed
PubMed Central
Google Scholar
Topic A, Ljujic M, Petrovic-Stanojevic N, Dopudja-Pantic V, Radojkovic D: Phenotypes and serum level of alpha-1-antitrypsin in lung cancer. J BUON. 2011, 16: 672-676.
CAS
PubMed
Google Scholar
Sekine C, Aoyagi Y, Suzuki Y, Ichida F: The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver. Br J Cancer. 1987, 56: 371-375. 10.1038/bjc.1987.205.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dabrowska M, Mantur M, Panasiuk A, Prokopowicz J: Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?. Neoplasma. 1997, 44: 305-307.
CAS
PubMed
Google Scholar
Tountas Y, Sparos L, Theodoropoulos C, Trichopoulos D: Alpha 1-antitrypsin and cancer of the pancreas. Digestion. 1985, 31: 37-40. 10.1159/000199175.
Article
CAS
PubMed
Google Scholar
Ward AM, Cooper EH, Houghton AL: Acute phase reactant proteins in prostatic cancer. Br J Urol. 1977, 49: 411-418. 10.1111/j.1464-410X.1977.tb04168.x.
Article
CAS
PubMed
Google Scholar
Latner AL, Turner GA, Lamin MM: Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix. Oncology. 1976, 33: 12-14. 10.1159/000225093.
Article
CAS
PubMed
Google Scholar
Zbroja-Sontag W: Defense proteins and immune complexes in the blood serum of women with inflammatory and neoplastic lesions of the ovary. Am J Reprod Immunol. 1983, 4: 11-20. 10.1111/j.1600-0897.1983.tb00247.x.
Article
CAS
PubMed
Google Scholar
Warwas M, Gerber J, Pietkiewicz A: Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary. Neoplasma. 1986, 33: 79-84.
CAS
PubMed
Google Scholar
Vasishta A, Baker PR, Preece PE, Wood RA, Cuschieri A: Serum proteinase-like peptidase activities and proteinase inhibitors in women with breast disease. Eur J Cancer Clin Oncol. 1984, 20: 197-202. 10.1016/0277-5379(84)90184-6.
Article
CAS
PubMed
Google Scholar
Dabrowska M, Kemona H, Prokopowicz J, Kiluk S: Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-1-antichymotrypsin in patients with Hodgkin’s disease. Mater Med Pol. 1992, 24: 28-30.
CAS
PubMed
Google Scholar
Krecicki T, Leluk M: Acute phase reactant proteins–an aid to monitoring surgical treatment of laryngeal carcinoma. J Laryngol Otol. 1992, 106: 613-615. 10.1017/S002221510012033X.
Article
CAS
PubMed
Google Scholar
Brkic S, Salkic A, Nuhbegovic S, Brkic F, Umihanic S: Influence of surgical therapy on serum values of alpha 1-antitrypsin in patients with head and neck tumors. Med Arh. 2011, 65: 99-101.
PubMed
Google Scholar
Karashima S, Kataoka H, Itoh H, Maruyama R, Koono M: Prognostic significance of a-1-antitrypsin in early stage of colorectal carcinomas. Int J Cancer. 1990, 45: 244-250. 10.1002/ijc.2910450207.
Article
CAS
PubMed
Google Scholar
Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R: An evaluation of the prognostic significance of a-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. Br J Cancer. 1992, 65: 300-302. 10.1038/bjc.1992.60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Glasgow JE, Bagdasarian A, Colman RW: Functional alpha 1 protease inhibitor produced by a human hepatoma cell line. J Lab Clin Med. 1982, 99: 108-117.
CAS
PubMed
Google Scholar
Kittas C, Aroni K, Kotsis L, Papadimitriou CS: Distribution of lysozyme, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1982, 398: 139-147. 10.1007/BF00618865.
Article
CAS
PubMed
Google Scholar
Tahara E, Ito H, Taniyama K, Yokozaki H, Hata J: Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study. Hum Pathol. 1984, 15: 957-964. 10.1016/S0046-8177(84)80125-2.
Article
CAS
PubMed
Google Scholar
Krugliak L, Meyer PR, Taylor CR: The distribution of lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in normal hematopoietic cells and in myeloid leukemias: an immunoperoxidase study on cytocentrifuge preparations, smears, and paraffin sections. Am J Hematol. 1986, 21: 99-109. 10.1002/ajh.2830210112.
Article
CAS
PubMed
Google Scholar
Meyer PR, Krugliak L, Neely S, Levine A, Parker JW, Kaplan B, Taylor CR: Acute leukemias with both myeloid and lymphoid surface markers. Cytoplasmic alpha-1-anti-chymotrypsin and alpha-1-anti-trypsin as possible indicators of early granulocytic differentiation. Am J Clin Pathol. 1986, 86: 461-468.
Article
CAS
PubMed
Google Scholar
Sawaya R, Zuccarello M, Highsmith R: Alpha-1-antitrypsin in human brain tumors. J Neurosurg. 1987, 67: 258-262. 10.3171/jns.1987.67.2.0258.
Article
CAS
PubMed
Google Scholar
Soini Y, Miettinen M: Alpha-1-antitrypsin and lysozyme. Their limited significance in fibrohistiocytic tumors. Am J Clin Pathol. 1989, 9: 515-521.
Article
Google Scholar
Kataoka H, Nabeshima K, Komada N, Koono M: New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro. Virchows Arch B Cell Pathol. 1989, 57: 157-165. 10.1007/BF02899077.
Article
CAS
Google Scholar
Kataoka H, Seguchi K, Inoue T, Koono M: Properties of a1-antitrypsin secreted by human adenocarcinoma cell lines. FEBS Lett. 1993, 328: 291-295. 10.1016/0014-5793(93)80946-R.
Article
CAS
PubMed
Google Scholar
Xie LQ, Zhao C, Cai SJ, Xu Y, Huang LY, Bian JS, Shen CP, Lu HJ, Yang PY: Novel proteomic strategy reveals combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J Proteome Res. 2010, 9: 4701-4709. 10.1021/pr100406z.
Article
CAS
PubMed
Google Scholar
Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, Wang WM: Discovery of tumor markers for gastric cancer by proteomics. PLoS One. 2014, 9: e84158-10.1371/journal.pone.0084158.
Article
PubMed
PubMed Central
Google Scholar
Huang H, Campbell SC, Nelius T, Bedford DF, Veliceasa D, Bouck NP, Volpert OV: Alpha1-antitrypsin inhibits angiogenesis and tumor growth. Int J Cancer. 2004, 112: 1042-1048. 10.1002/ijc.20494.
Article
CAS
PubMed
Google Scholar
Keppler D, Markert M, Carnal B, Berdoz J, Bamat J, Sordat B: Human colon carcinoma cells synthesize and secrete alpha 1-proteinase inhibitor. Biol Chem Hoppe Seyler. 1996, 377: 301-311. 10.1515/bchm3.1996.377.5.301.
Article
CAS
PubMed
Google Scholar
Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, Mignatti P: Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001, 189: 197-206. 10.1002/jcp.10014.
Article
CAS
PubMed
Google Scholar
Kataoka H, Uchino H, Iwamura T, Seiki M, Nabeshima K, Koono M: Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am J Pathol. 1999, 154: 457-468. 10.1016/S0002-9440(10)65292-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perlmutter DH, Daniels JD, Auerbach HS, De Schryver-Kecskemeti K, Winter HS, Alpers DH: The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem. 1989, 264: 9485-9490.
CAS
PubMed
Google Scholar
Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, Calvo F, Seidah NG, Khatib AM: Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest. 2008, 118: 352-363. 10.1172/JCI32040.
Article
CAS
PubMed
Google Scholar
Nejjari M, Berthet V, Rigot V, Laforest S, Jacquier MF, Seidah NG, Remy L, Bruyneel E, Scoazec JY, Marvaldi J, Luis J: Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am J Pathol. 2004, 164: 1925-1933. 10.1016/S0002-9440(10)63753-4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khatib AM, Siegfried G, Prat A, Luis J, Chrétien M, Metrakos P, Seidah NG: Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem. 2001, 276: 30686-30693. 10.1074/jbc.M101725200.
Article
CAS
PubMed
Google Scholar